CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320271970
- Phone
- (617)500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-20 | Srivastava Sapna Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2024-06-20 | Johnson David Michael Director | Grant or award | +10,500 | 146,167 | ||
| 2024-06-20 | Johnson David Michael Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2024-04-02 | Kilroy Conor General Counsel and Secretary | Grant or award | +96,000 | 96,000 | ||
| 2024-04-02 | Kilroy Conor General Counsel and Secretary | Grant or award · Stock Option (Right to Buy) | +144,000 | 144,000 | ||
| 2024-02-01 | Feder Julie B Chief Financial Officer | Grant or award | +71,285 | 134,276 | ||
| 2024-02-01 | Feder Julie B Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +103,715 | 103,715 | ||
| 2024-02-01 | Hopkins Janet Jill Chief Medical Officer | Grant or award | +28,515 | 163,515 | ||
| 2024-02-01 | Hopkins Janet Jill Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +41,485 | 41,485 | ||
| 2024-02-01 | de los Pinos Elisabet See Remarks | Grant or award | +162,935 | 324,373 | ||
| 2024-02-01 | de los Pinos Elisabet See Remarks | Grant or award · Stock Option (Right to Buy) | +237,065 | 237,065 | ||
| 2024-01-23 | de los Pinos Elisabet See Remarks | Sale | −15,853 | $7.64 | $121K | 161,438 |
| 2024-01-23 | Feder Julie B Chief Financial Officer | Sale | −6,609 | $7.64 | $51K | 62,991 |
| 2023-11-09 | Matrix Capital Management Company, LP 10% owner | Purchase | +1,560,000 | $9.00 | $14.0M | 6,922,870 |
| 2023-11-08 | Johnson David Michael Director | Purchase | +9,601 | $7.30 | $70K | 135,667 |
| 2023-11-08 | Johnson David Michael Director | Purchase | +10,000 | $7.30 | $73K | 75,000 |
| 2023-11-08 | Johnson David Michael Director | Purchase | +10,000 | $7.30 | $73K | 75,000 |
| 2023-11-07 | Johnson David Michael Director | Purchase | +76,000 | $7.17 | $545K | 126,066 |
| 2023-11-07 | Johnson David Michael Director | Purchase | +47,000 | $7.17 | $337K | 65,000 |
| 2023-11-07 | Johnson David Michael Director | Purchase | +47,000 | $7.17 | $337K | 65,000 |
Page 7 of 11 · 219 trades